Assessing Case Fatality on Cases of Thrombosis with Concurrent Thrombocytopenia Following COVID-19 Vaccine AstraZeneca (Vaxzevria) in the United Kingdom: A Review of Spontaneously Reported Data

INTRODUCTION: Thrombotic thrombocytopenia syndrome (TTS) events were reported very rarely following the coronavirus disease 2019 (COVID-19) vaccine AstraZeneca (Vaxzevria). Clinical and demographic characteristics of the affected people, including the outcomes of TTS events, need to be examined usin...

Descripción completa

Detalles Bibliográficos
Autores principales: Lane, Samantha, Shakir, Saad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362462/
https://www.ncbi.nlm.nih.gov/pubmed/35927605
http://dx.doi.org/10.1007/s40264-022-01217-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362462/
https://www.ncbi.nlm.nih.gov/pubmed/35927605
http://dx.doi.org/10.1007/s40264-022-01217-9

Ejemplares similares